Chungju-si, South Korea

Sangryul Lee




Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: The Innovative Contributions of Sangryul Lee in Cancer Treatment

Introduction

Sangryul Lee is an esteemed inventor based in Chungju-si, South Korea, known for his significant contributions to the field of cancer treatment. With a focus on pharmaceutical innovations, Lee has developed a compound that addresses critical resistance mechanisms in certain cancer cells. His work at Oncobix Co., Ltd. showcases the potential of modern medical research to significantly enhance treatment options for patients.

Latest Patents

Sangryul Lee holds a patent for a pyrimidine derivative compound that demonstrates remarkable efficacy in inhibiting cancer cell growth. The patent, titled "Pyrimidine derivative having effect of inhibiting cancer cell growth and pharmaceutical composition containing same," outlines a novel compound and its salt forms. This pyrimidine derivative specifically targets C797S mutant EGFR-expressed and MET-amplified cancer cells, providing a promising avenue for the treatment of lung cancer.

Career Highlights

Throughout his career, Sangryul Lee has dedicated his efforts to innovative research in oncology. His groundbreaking patent signifies a major advancement in understanding and overcoming the resistance posed by specific cancer cell types to third-generation EGFR anticancer agents. Lee's commitment to improving cancer treatments is evident in his work and the relevance of his findings in clinical applications.

Collaborations

In the pursuit of his research goals, Sangryul Lee collaborates with talented professionals, including coworkers Sung-Eun Kim and Sunho Lee. These collaborations enrich the research environment at Oncobix Co., Ltd. and foster an innovative culture that emphasizes teamwork and shared expertise.

Conclusion

Sangryul Lee's contributions to cancer pharmacology position him as a pivotal figure in the ongoing battle against cancer. His patent for a pyrimidine derivative compound not only reflects his innovative spirit but also holds the promise of improving therapeutic outcomes for lung cancer patients. As research continues to evolve, the impact of Lee's work is poised to resonate throughout the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…